Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LGND

Ligand Pharmaceuticals Inc

May 29 • 04:00PM ET

231.96

-2.70 -1.15 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN IONS RYTM VKTX ALNY INCY AXSM MDGL KROS NBIX

| Held by: IJR VTI IWM VB VBR VXF SPSM IJT XSMO IWN

Scroll to Statements

Index	RUT	P/E	31.45	EPS (ttm)	7.38	Insider Own	2.39%	Shs Outstand	20.03M	Perf Week	4.40%
Market Cap	4.65B	Forward P/E	20.84	EPS next Y	11.13	Insider Trans	-8.29%	Shs Float	19.56M	Perf Month	3.16%
Enterprise Value	4.32B	PEG	1.26	EPS next Q	1.99	Inst Own	104.60%	Short Float	7.70%	Perf Quarter	16.97%
Income	153.56M	P/S	16.94	EPS this Y	11.41%	Inst Trans	0.71%	Short Ratio	6.55	Perf Half Y	13.97%
Sales	274.48M	P/B	4.66	EPS next Y	22.87%	ROA	12.60%	Short Interest	1.51M	Perf YTD	22.68%
Book/sh	49.79	P/C	5.96	EPS next 5Y	16.58%	ROE	17.13%	52W High	247.38 -6.23%	Perf Year	129.87%
Cash/sh	38.89	P/FCF	37.76	EPS past 3/5Y	- -	ROIC	10.60%	52W Low	98.89 134.56%	Perf 3Y	221.59%
Dividend Est.	-	EV/EBITDA	31.83	Sales past 3/5Y	10.96% 7.54%	Gross Margin	83.42%	Volatility	3.17% 4.08%	Perf 5Y	205.41%
Dividend TTM	-	EV/Sales	15.74	EPS Y/Y TTM	210.12%	Oper. Margin	36.88%	ATR (14)	8.89	Perf 10Y	192.71%
Dividend Ex-Date	Jul 02, 2010	Quick Ratio	20.95	Sales Y/Y TTM	51.24%	Profit Margin	55.95%	RSI (14)	57.37	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	21.28	EPS Q/Q	69.66%	SMA20	3.76%	Beta	1.21	Target Price	277.11
Payout	0.00%	Debt/Eq	0.45	Sales Q/Q	14.09%	SMA50	6.30%	Rel Volume	0.65	Prev Close	234.66
Employees	47	LT Debt/Eq	0.45	Earnings	May 07 BMO	SMA200	18.87%	Avg Volume	229.93K	Price	231.96
IPO	Nov 18, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	-10.23% -11.88%	Trades		Volume	150,495	Change	-1.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)